|
|
Volumn 19, Issue 10, 2011, Pages 3204-3215
|
|
Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents
a
|
|
Author keywords
Antibacterial activity; Indolic derivatives; Substituted hydroxylamines
|
|
Indexed keywords
1 (1H INDOL 3 YL)ETHANAMINE DERIVATIVE;
ANTIINFECTIVE AGENT;
INDOLE DERIVATIVE;
N BENZYL N [1 (1H INDOL 3 YL) 3 METHYLBUTYL]HYDROXYLAMINE;
N BENZYL N [1 (1H INDOL 3 YL)ETHYL]HYDROXYLAMINE;
N BENZYL N [1 (5 BROMO 1H INDOL 3 YL) 3 METHYLBUTYL]HYDROXYLAMINE;
N BENZYL N [1 (5 BROMO 1H INDOL 3 YL)ETHYL]HYDROXYLAMINE;
N BENZYL N [1 (5 CHLORO 1H INDOL 3 YL) 3 METHYLBUTYL]HYDROXYLAMINE;
N BENZYL N [1 (5 CHLORO 1H INDOL 3 YL)ETHYL]HYDROXYLAMINE;
N BENZYL N [1 (5 FLUORO 1H INDOL 3 YL) 3 METHYLBUTYL]HYDROXYLAMINE;
N BENZYL N [1 (5 FLUORO 1H INDOL 3 YL)ETHYL]HYDROXYLAMINE;
N BENZYL N [1 (5 IODO 1H INDOL 3 YL) 3 METHYLBUTYL]HYDROXYLAMINE;
N BENZYL N [1 (5 IODO 1H INDOL 3 YL)ETHYL]HYDROXYLAMINE;
N BENZYLIDENE 1 (1H INDOL 3 YL) 3 METHYLBUTANE 1 AMINE OXIDE;
N BENZYLIDENE 1 (1H INDOL 3 YL)ETHANAMINE OXIDE;
N BENZYLIDENE 1 (5 BROMO 1H INDOL 3 YL)ETHANAMINE OXIDE;
N BENZYLIDENE 1 (5 CHLORO 1H INDOL 3 YL)ETHANAMINE OXIDE;
N BENZYLIDENE 1 (5 FLUORO 1H INDOL 3 YL) 3 METHYLBUTANE 1 AMINE OXIDE;
N BENZYLIDENE 1 (5 FLUORO 1H INDOL 3 YL)ETHANAMINE OXIDE;
N BENZYLIDENE 1 (5 IODO 1H INDOL 3 YL)ETHANAMINE OXIDE;
TERT BUTYL 2 (BENZYL(HYDROXY)AMINO) 2 (1H INDOL 3 YL)ETHYLCARBAMATE;
TERT BUTYL 2 (BENZYL(HYDROXY)AMINO) 2 (5 FLUORO 1H INDOL 3 YL)ETHYLCARBAMATE;
TERT BUTYL 2 [BENZYL(HYDROXY)AMINO] 2 (4 BROMO 1H INDOL 3 YL)ETHYLCARBAMATE;
TERT BUTYL 2 [BENZYL(HYDROXY)AMINO] 2 (5 BROMO 1H INDOL 3 YL)ETHYLCARBAMATE;
TERT BUTYL 2 [BENZYL(HYDROXY)AMINO] 2 (5 CHLORO 1H INDOL 3 YL)ETHYLCARBAMATE;
TERT BUTYL 2 [BENZYL(HYDROXY)AMINO] 2 (5 IODO 1H INDOL 3 YL)ETHYLCARBAMATE;
TERT BUTYL 2 [BENZYL(HYDROXY)AMINO] 2 (6 BROMO 1H INDOL 3 YL)ETHYLCARBAMATE;
TERT BUTYL 2 [BENZYL(HYDROXY)AMINO] 2 (6 CHLORO 1H INDOL 3 YL)ETHYLCARBAMATE;
TERT BUTYL 2 [BENZYL(HYDROXY)AMINO] 2 (6 FLUORO 1H INDOL 3 YL)ETHYLCARBAMATE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACTERIAL STRAIN;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
GROWTH INHIBITION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
NUCLEOPHILICITY;
STAPHYLOCOCCUS AUREUS;
VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS;
ANTI-BACTERIAL AGENTS;
BACTERIA;
BACTERIAL INFECTIONS;
HUMANS;
INDOLES;
MICROBIAL SENSITIVITY TESTS;
STAPHYLOCOCCAL INFECTIONS;
STAPHYLOCOCCUS AUREUS;
STRUCTURE-ACTIVITY RELATIONSHIP;
BACTERIA (MICROORGANISMS);
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
STAPHYLOCOCCUS AUREUS;
|
|
EID: 79956191508
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2011.03.060 Document Type: Article |
|
Times cited : (21)
|
|
References (37)
|
